Harmony Biosciences Holdings, Inc. (HRMY)

Capital Fund Management S.A. bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) during the second quarter, according to the company in its most recent disclosure with the Securiti...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will highlight new open-label extension data from the company's investigation of EPX-...

Boston Partners purchased a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) in the undefined quarter, according to the company in its most recent filing with the Securities...

American Century Companies Inc. grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) by 16.5% in the second quarter, according to its most recent disclosure with the SEC. The fund ow...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced positive results from its pivotal bioequivalence (BE) study evaluating pitolisant gastro-resis...

Envestnet Asset Management Inc. decreased its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) by 27.3% during the undefined quarter, according to its most recent filing with th...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced dosing of the first participant in a Phase 1 clinical trial of BP1.15205, an investigational, ...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in the following upcoming investor conference...